To verify whether modulating the expression of ETV7 in the opposite direction could also affect the population of CD44+/CD24− cells, we silenced the expression of ETV7 in the aggressive triple negative BC-derived cell line MDA-MB-231, which is known from the literature to present almost exclusively CD44+/CD24− cells [55]. The gene discussed is CD44; the disease is breast cancer.